TABLE 1.
Significance of correlation or association between possible risk factors and MFD loss
| Nominal P value | Correlation | |
|---|---|---|
| Most bothersome symptom | 0.58 | NA |
| Total clinical symptom score | 0.44 | −0.038 |
| Toe vibration perception | 0.40 | −0.041 |
| Left-finger vibration perception | 0.43 | −0.038 |
| Right-finger vibration perception | 0.96 | −0.003 |
| Dominant peroneal motor NCV | 0.005 | 0.136 |
| Dominant peroneal motor amplitude (knee) | 0.71 | 0.018 |
| Dominant peroneal motor amplitude (ankle) | 0.77 | 0.014 |
| Sural sensory NCV | 0.05 | 0.095 |
| Sural sensory nerve amplitude | 0.42 | 0.039 |
| Nondominant median motor NCV | 0.02 | 0.110 |
| Nondominant median motor amplitude (elbow) | 0.90 | 0.006 |
| Nondominant median motor amplitude (wrist) | 0.83 | −0.011 |
| Nondominant median sensory NCV (elbow) | 0.08 | 0.086 |
| Nondominant median sensory amplitude (elbow) | 0.05 | 0.094 |
| Nondominant median sensory NCV (wrist) | 0.36 | 0.045 |
| Nondominant median sensory amplitude (wrist) | 0.27 | 0.053 |
| A1C | 0.012 | −0.115 |
| Triglycerides | 0.02 | −0.110 |
| BMI | 0.54 | −0.029 |
| Cholesterol | 0.27 | −0.053 |
| Hematocrit | 0.84 | 0.010 |
| Serum albumin | 0.46 | −0.036 |
| Diabetes duration | 0.07 | 0.086 |
| Age | 0.13 | −0.074 |
| Insulin | 0.46 | NA |
| Sex | 0.10 | NA |
| Drug treatment | 0.87 | NA |
NA, not applicable.